Explorations of peptide and oligonucleotide binding sites of tyrosyl-DNA phosphodiesterase using vanadate complexes

被引:45
作者
Davies, DR
Interthal, H
Champoux, JJ
Hol, WGJ
机构
[1] Univ Washington, Sch Med, Dept Biochem, Seattle, WA 98195 USA
[2] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA
[3] Biomol Struct Ctr, Seattle, WA 98195 USA
[4] Howard Hughes Med Inst, Seattle, WA 98195 USA
关键词
D O I
10.1021/jm030487x
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Tyrosyl-DNA phosphodiesterase (Tdp1) catalyzes the hydrolysis of a phosphodiester bond between a tyrosine residue and a DNA 3' phosphate and functions as a DNA repair enzyme that cleaves stalled topoisomerase I-DNA complexes. We previously determined a procedure to crystallize a quaternary complex containing Tdp1, vanadate, a DNA oligonucleotide, and a tyrosine-containing peptide that mimics the transition state for hydrolysis of the Tdp1 substrate. Here, the ability of vanadate to accept a variety of different ligands is exploited to produce several different quaternary complexes with a variety of oligonucleotides, and peptides or a tyrosine analogue, in efforts to explore the binding properties of the Tdp1 DNA and peptide binding clefts. Eight crystal structures of Tdp1 with vanadate, oligonucleotides, and peptides or peptide analogues were determined. These structures demonstrated that Tdp1 is able to bind substituents with limited sequence variation in the polypeptide moiety and also bind oligonucleotides with sequence variation at the 3' end. Additionally, the tyrosine analogue octopamine can replace topoisomerase I derived peptides as the apical ligand to vanadate. The versatility of this system suggests that the formation of quaternary complexes around vanadate could be adapted to become a useful method for structure-based inhibitor design and has the potential to be generally applicable to other enzymes that perform chemistry on phosphate esters.
引用
收藏
页码:829 / 837
页数:9
相关论文
共 25 条
[1]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[2]   NUCLEOTIDE-SEQUENCE PREFERENCE AT RAT-LIVER AND WHEAT-GERM TYPE-1 DNA TOPOISOMERASE BREAKAGE SITES IN DUPLEX SV40 DNA [J].
BEEN, MD ;
BURGESS, RR ;
CHAMPOUX, JJ .
NUCLEIC ACIDS RESEARCH, 1984, 12 (07) :3097-3114
[3]   Effects of camptothecin, a topoisomerase I inhibitor, on Plasmodium falciparum [J].
Bodley, AL ;
Cumming, JN ;
Shapiro, TA .
BIOCHEMICAL PHARMACOLOGY, 1998, 55 (05) :709-711
[4]   Ribbons [J].
Carson, M .
MACROMOLECULAR CRYSTALLOGRAPHY, PT B, 1997, 277 :493-505
[5]   Crystal structure of a transition state mimic for Tdp1 assembled from vanadate, DNA, and a topoisomerase I-derived peptide [J].
Davies, DR ;
Interthal, H ;
Champoux, JJ ;
Hol, WGJ .
CHEMISTRY & BIOLOGY, 2003, 10 (02) :139-147
[6]   Insights into substrate binding and catalytic mechanism of human tyrosyl-DNA phosphodiesterase (Tdp1) from vanadate and tungstate-inhibited structures [J].
Davies, DR ;
Interthal, H ;
Champoux, JJ ;
Hol, WGJ .
JOURNAL OF MOLECULAR BIOLOGY, 2002, 324 (05) :917-932
[7]   The crystal structure of human tyrosyl-DNA phosphodiesterase, Tdp1 [J].
Davies, DR ;
Interthal, H ;
Champoux, JJ ;
Hol, WGJ .
STRUCTURE, 2002, 10 (02) :237-248
[8]  
GORDON JA, 1991, METHOD ENZYMOL, V201, P477
[9]   Conversion of phosphoglycolate to phosphate termini on 3′ overhangs of DNA double strand breaks by the human tyrosyl-DNA phosphodiesterase hTdp1 [J].
Inamdar, KV ;
Pouliot, JJ ;
Zhou, T ;
Lees-Miller, SP ;
Rasouli-Nia, A ;
Povirk, LF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (30) :27162-27168
[10]   The tyrosyl-DNA phosphodiesterase Tdp1 is a member of the phospholipase D superfamily [J].
Interthal, H ;
Pouliott, JJ ;
Champoux, JJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (21) :12009-12014